Effects of Sensorimotor Balance Training vs Digitally Augmented Core Stabilization in Women With Osteoporosis

November 17, 2026 updated by: Riphah International University

Effects of Sensorimotor-Based Balance Training Versus Digitally Augmented Core Stabilization on Postural Control and Fall Risk in Postmenopausal Women With Osteoporosis

This randomized controlled trial aims to compare the effects of sensorimotor-based balance training and digitally augmented core stabilization on postural control and fall risk in postmenopausal women with osteoporosis. Osteoporosis is a common condition in postmenopausal women that can impair balance, reduce functional mobility, and increase the risk of falls and fractures. Eligible participants will be randomly assigned to one of two intervention groups. Group A will receive a structured sensorimotor-based balance training program, while Group B will receive a digitally augmented core stabilization exercise program supported through the HEP2Go platform and monitored via WhatsApp. Both groups will receive supervised physiotherapy sessions three times per week for 8 weeks. Outcome measures including postural control, fall risk, spinal alignment, core muscle endurance, proprioception, muscle strength, adherence, and usability will be assessed before and after the intervention. The findings of this study may provide evidence regarding effective physiotherapy strategies for improving balance and reducing fall risk in postmenopausal women with osteoporosis.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Osteoporosis is a progressive skeletal disorder characterized by reduced bone mineral density and deterioration of bone microarchitecture, resulting in increased bone fragility and susceptibility to fractures. Postmenopausal women are particularly affected because estrogen deficiency accelerates bone loss, leading to impaired postural stability, reduced muscle strength, proprioceptive deficits, and an increased risk of falls. Falls are a major cause of morbidity, disability, and reduced quality of life among women with osteoporosis.

Exercise-based physiotherapy is an important non-pharmacological intervention for improving balance, postural control, muscle strength, and functional mobility in individuals with osteoporosis. Sensorimotor-based balance training aims to improve proprioception, neuromuscular coordination, and postural stability through progressively challenging balance and functional activities. Core stabilization exercises focus on strengthening deep trunk muscles to improve spinal stability, posture, and movement control.

Digital rehabilitation technologies have increasingly been incorporated into physiotherapy practice to improve exercise adherence, accessibility, and patient engagement. In this study, digital augmentation will be delivered through the HEP2Go platform by providing individualized home exercise programs with exercise illustrations and written instructions. Participants in the digitally augmented group will also receive regular follow-up and adherence monitoring through WhatsApp communication with the assistance of caregivers.

This study will be conducted as a randomized controlled trial involving postmenopausal women diagnosed with osteoporosis. Eligible participants who satisfy the inclusion criteria and provide written informed consent will undergo baseline assessment and then be randomly allocated to one of two intervention groups. Group A will receive a structured sensorimotor-based balance training program, whereas Group B will receive a digitally augmented core stabilization exercise program. Both interventions will be administered three times per week for 8 weeks.

Primary outcomes include postural control and fall risk. Secondary outcomes include thoracic kyphosis angle, core muscle endurance, lumbar joint position sense, trunk extensor strength, exercise adherence, and system usability. Outcome measures will be recorded before and after completion of the intervention using standardized assessment tools. Data will be analyzed using SPSS version 26 to compare within-group and between-group changes.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Federal
      • Islamabad, Federal, Pakistan, 44000
        • Recruiting
        • Muhammad Adnan Saeed
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • PMW diagnosed with osteoporosis through DEXA (T-score ≤ -2.5)
  • Age (45-70 years).
  • Able to participate in sessions and walk independently.
  • Mild to moderate Balance impairment as per BBS

Exclusion Criteria:

  • • Women with severe mobility impairments.

    • History of fragility fracture within the last 6 months
    • Women with cognitive conditions affecting participation.
    • Women with lower limb joint injury or surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sensorimotor-Based Balance Training

Participants assigned to this arm will receive a structured sensorimotor-based balance training program aimed at improving postural control, proprioception, balance, and reducing fall risk in postmenopausal women with osteoporosis. The intervention consists of warm-up exercises, static and dynamic balance training, sensorimotor and proprioceptive exercises, gait and functional training, lower-limb strengthening exercises, and cool-down activities. Supervised physiotherapy sessions will be conducted three times per week for 8 weeks, with progressive exercise intensity according to participant tolerance.

A supervised sensorimotor-based balance training program comprising progressive static and dynamic balance exercises, proprioceptive training, gait training, lower-limb strengthening, functional balance activities, and cool-down exercises. Sessions will be conducted three times per week for 8-12 weeks to improve postural control, balance, and functional mobility in postmenopausal women with osteoporosis.

Experimental: Digitally Augmented Core Stabilization

Participants assigned to this arm will receive a structured core stabilization exercise program enhanced through digital augmentation using the HEP2Go platform. Individualized home exercise programs containing exercise illustrations and written instructions will be provided through HEP2Go. The intervention includes warm-up, deep core muscle activation, core stabilization exercises, functional core training, postural training, and cool-down exercises. Supervised physiotherapy sessions will be conducted three times per week for 8 weeks. Exercise adherence and progress will be monitored through regular WhatsApp communication with participants and their caregivers.

A supervised core stabilization exercise program focusing on activation and strengthening of deep trunk muscles, postural alignment, and functional stability. Digital augmentation will be provided through the HEP2Go platform by delivering individualized home exercise programs with exercise illustrations and written instructions. Participants will also receive regular WhatsApp reminders, educational support, and adherence monitoring throughout the 8-12-week intervention period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postural Control (Mini-BESTest)
Time Frame: Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Postural control will be assessed using the Mini-Balance Evaluation Systems Test (Mini-BESTest), a 14-item clinical measure of postural control. Total scores range from 0 to 28 points, with higher scores indicating better postural control.

Baseline (pre-intervention) and immediately after completion of the 8-week intervention.
Fall Risk
Time Frame: Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Fall risk will be assessed using the Timed Up and Go (TUG) Test. Time is recorded in seconds, with shorter completion times indicating better functional mobility and lower fall risk.

Baseline (pre-intervention) and immediately after completion of the 8-week intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thoracic Kyphosis Angle
Time Frame: Baseline and immediately after completion of the 8-week intervention.

Thoracic kyphosis angle will be measured using a Flexicurve ruler.

Baseline and immediately after completion of the 8-week intervention.
Core Muscle Endurance
Time Frame: Baseline and immediately after completion of the 8-week intervention

core muscle endurance will be assessed using the Modified McGill Trunk Endurance Test.

Baseline and immediately after completion of the 8-week intervention
Proprioception
Time Frame: Baseline and immediately after completion of the 8-week intervention.

Lumbar proprioception will be assessed using the lumbar joint position sense repositioning error test.

Baseline and immediately after completion of the 8-week intervention.
Trunk Extensor Muscle Strength
Time Frame: Baseline and immediately after completion of the 8-week intervention.

Trunk extensor muscle strength will be measured using a handheld dynamometer.

Baseline and immediately after completion of the 8-week intervention.
Exercise Adherence
Time Frame: Throughout the 8-week intervention period.

Exercise adherence will be evaluated using attendance records and home exercise adherence logs throughout the intervention period.

Throughout the 8-week intervention period.
System Usability
Time Frame: At the end of the 8-week intervention.

System usability of the digitally augmented intervention will be assessed using the System Usability Scale (SUS). The SUS consists of 10 items and provides a total score ranging from 0 to 100 points, with higher scores indicating better perceived usability of the digitally augmented intervention.

At the end of the 8-week intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Huma Riaz, Riphah International University, Islamabad

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 19, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

July 31, 2027

Study Registration Dates

First Submitted

September 16, 2026

First Submitted That Met QC Criteria

October 11, 2026

First Posted (Actual)

October 15, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 17, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Hadia

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared publicly because the dataset contains confidential participant information collected for an academic research project. Data will be stored securely and used only for the purposes of this study. Any future sharing of de-identified data will require approval from the Institutional Review Board/Ethics Committee and the principal investigator, in accordance with institutional policies and participant consent.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.